DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression
Advanced Science · 2023-06 · 10 (16)
DOI: 10.1002/advs.202206707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.04.2023. Verfasst von Zuqin Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, No. 28 Fuxing Road, Beijing, 100853, P. R. China. Hauptthemen laut MEDLINE: Mitoxantrone, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research & Development Program of China, National Natural Science Foundation of China, National Natural Science Foundation of China (NSFC) key project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Patients with triple‐negative breast cancer (TNBC) have the worst clinical outcomes when compared to other subtypes of breast cancer. Nanotechnology‐assisted photothermal therapy (PTT) opens new opportunities for precise cancer treatment. However, thermoresistance caused by PTT, as well as uncertainty in the physiological metabolism of existing phototherapeutic nanoformulations, severely limit their clinical applications. Herein, based on the clinically chemotherapeutic drug mitoxantrone (MTO), a multifunctional nanoplatform (MTO‐micelles) is developed to realize mutually synergistic mild‐photothermal chemotherapy. MTO with excellent near‐infrared absorption (≈669 nm) can function not only as a chemotherapeutic agent but also as a photothermal transduction agent with elevated photothermal conversion efficacy ( ƞ = 54.62%). MTO‐micelles can accumulate at the tumor site through the enhanced permeability and retention effect. Following local near‐infrared irradiation, mild hyperthermia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Chinese PLA, No. 28 Fuxing Road, Beijing, 100853, P. R. China.
- Department of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, P. R. China.
- School of Microelectronics, Shanghai University, Shanghai, 201800, P. R. China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, P. R. China.
- Department of Medical Imaging, Chinese PAP Force Hospital of Beijing, Beijing, 100600, P. R. China.
ORCID-Profile: Xing-Jie Liang, Yueyong Xiao
Förderung
- National Key Research & Development Program of China
- National Natural Science Foundation of China
- National Natural Science Foundation of China (NSFC) key project
- NSFC international collaboration key project
- China Postdoctoral Science Foundation
- Beijing-Tianjin-Hebei Basic Research Cooperation
- Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province
Zitieren
APA
Chen, Z., Li, S., Li, F., Qin, C., Li, X., Qing, G., Wang, J., Xia, B., Zhang, F., Meng, L., Liang, X. J., & Xiao, Y. (2023). DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression. Advanced Science, 10(16). https://doi.org/10.1002/advs.202206707
Vancouver
Chen Z, Li S, Li F, Qin C, Li X, Qing G, et al. DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression. Advanced Science. 2023;10(16). doi:10.1002/advs.202206707
BibTeX
@article{Chen2023,
author = {Chen, Zuqin and Li, Sunfan and Li, Fangzhou and Qin, Cheng and Li, Xianlei and Qing, Guangchao and Wang, Jinjin and Xia, Bozhang and Zhang, Fuxue and Meng, Liangliang and Liang, Xing-Jie and Xiao, Yueyong},
title = {DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {16},
doi = {10.1002/advs.202206707}
}
EUVIMED